ITRM – Iterum Therapeutics Plc
Iterum Therapeutics plcITRM
$0.9384Name : Iterum Therapeutics plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $32,451,184.00
EPSttm : -1.26
Iterum Therapeutics plc
$0.9384
7.09%$0.0716Float Short %
2.75
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.12
EPS Last/This Y
1.26
EPS This/Next Y
Price
0.94
Target Price
7
Analyst Recom
1
Performance Q
-27.82
Relative Volume
2.68
Beta
2.82
Ticker: ITRM
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | ITRM | 1.11 | N/A | N/A | 0 |
| 2025-04-15 | ITRM | 1.11 | N/A | N/A | 0 |
| 2025-04-16 | ITRM | 1.05 | N/A | N/A | 0 |
| 2025-04-17 | ITRM | 1.06 | N/A | N/A | 0 |
| 2025-04-18 | ITRM | 1.08 | N/A | N/A | 0 |
| 2025-04-21 | ITRM | 1.03 | N/A | N/A | 0 |
| 2025-04-22 | ITRM | 1.1 | N/A | N/A | 0 |
| 2025-04-23 | ITRM | 1.39 | N/A | N/A | 0 |
| 2025-04-24 | ITRM | 1.3 | N/A | N/A | 0 |
| 2025-04-25 | ITRM | 1.26 | N/A | N/A | N/A |
| 2025-04-28 | ITRM | 1.26 | N/A | N/A | N/A |
| 2025-04-29 | ITRM | 1.06 | N/A | N/A | 0 |
| 2025-04-30 | ITRM | 1.115 | N/A | N/A | 0 |
| 2025-05-01 | ITRM | 1.075 | N/A | N/A | 0 |
| 2025-05-02 | ITRM | 1.095 | N/A | N/A | 0 |
| 2025-05-05 | ITRM | 1.055 | N/A | N/A | 0 |
| 2025-05-06 | ITRM | 0.9955 | N/A | N/A | 0 |
| 2025-05-07 | ITRM | 0.9278 | N/A | N/A | 0 |
| 2025-05-08 | ITRM | 1.055 | N/A | N/A | 0 |
| 2025-05-09 | ITRM | 1.02 | N/A | N/A | 0 |
| 2025-05-12 | ITRM | 1.01 | N/A | N/A | 0 |
| 2025-05-13 | ITRM | 0.9365 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | ITRM | 1.13 | - | - | 0.00 |
| 2025-04-15 | ITRM | 1.12 | - | - | 0.00 |
| 2025-04-16 | ITRM | 1.05 | - | - | 0.00 |
| 2025-04-17 | ITRM | 1.08 | - | - | 0.00 |
| 2025-04-18 | ITRM | 1.08 | - | - | 0.00 |
| 2025-04-21 | ITRM | 1.02 | - | - | 0.00 |
| 2025-04-22 | ITRM | 1.11 | - | - | 0.00 |
| 2025-04-23 | ITRM | 1.39 | - | - | 0.00 |
| 2025-04-24 | ITRM | 1.30 | - | - | 0.00 |
| 2025-04-25 | ITRM | 1.26 | - | - | 0.00 |
| 2025-04-28 | ITRM | 1.26 | - | - | 0.00 |
| 2025-04-29 | ITRM | 1.06 | - | - | 0.00 |
| 2025-04-30 | ITRM | 1.12 | - | - | 0.00 |
| 2025-05-01 | ITRM | 1.07 | - | - | 0.00 |
| 2025-05-02 | ITRM | 1.10 | - | - | 0.00 |
| 2025-05-05 | ITRM | 1.06 | - | - | 0.00 |
| 2025-05-06 | ITRM | 1.00 | - | - | 0.00 |
| 2025-05-07 | ITRM | 0.92 | - | - | 0.00 |
| 2025-05-08 | ITRM | 1.05 | - | - | 0.00 |
| 2025-05-09 | ITRM | 1.02 | - | - | 0.00 |
| 2025-05-12 | ITRM | 1.01 | - | - | 0.00 |
| 2025-05-13 | ITRM | 0.94 | - | 8.6 | 0.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-15 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-16 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-17 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-18 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-21 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-22 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-23 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-24 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-25 | ITRM | 0.00 | 31.30 | 4.43 |
| 2025-04-28 | ITRM | 0.00 | 31.30 | 3.67 |
| 2025-04-29 | ITRM | 0.00 | 31.30 | 3.67 |
| 2025-04-30 | ITRM | 0.00 | 31.30 | 3.67 |
| 2025-05-01 | ITRM | 0.00 | 31.30 | 3.67 |
| 2025-05-02 | ITRM | 0.00 | 31.30 | 3.67 |
| 2025-05-05 | ITRM | 0.00 | 31.11 | 3.67 |
| 2025-05-06 | ITRM | 0.00 | 31.11 | 3.67 |
| 2025-05-07 | ITRM | 0.00 | 31.11 | 3.28 |
| 2025-05-08 | ITRM | 0.00 | 31.11 | 3.28 |
| 2025-05-09 | ITRM | 0.00 | 31.11 | 3.28 |
| 2025-05-12 | ITRM | 0.00 | 29.61 | 2.75 |
| 2025-05-13 | ITRM | 0.00 | 29.61 | 2.75 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.12
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
29.61
Beta
2.82
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
Fair Value
Quality Score
4
Growth Score
25
Sentiment Score
34
Actual DrawDown %
98.9
Max Drawdown 5-Year %
-99
Target Price
7
P/E
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
-1.31
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
2.68
Return on Equity vs Sector %
583.4
Return on Equity vs Industry %
600.3
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
8.6
Iterum Therapeutics plcSector: Healthcare
Industry: Biotechnology
Employees: 9
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
stock quote shares ITRM – Iterum Therapeutics Plc Stock Price stock today
news today ITRM – Iterum Therapeutics Plc stock forecast ,stock prediction 2023 2024 2025
marketwatch ITRM – Iterum Therapeutics Plc yahoo finance google finance
stock history ITRM – Iterum Therapeutics Plc invest stock market
stock prices ITRM premarket after hours
ticker ITRM fair value insiders trading